Hydrogen peroxide-generating nanomedicine for enhanced chemodynamic therapy

Peng Yu,Xiaodong Li,Guohui Cheng,Xu Zhang,Dan Wu,Jin Chang,Sheng Wang
DOI: https://doi.org/10.1016/j.cclet.2021.02.015
IF: 9.1
2021-07-01
Chinese Chemical Letters
Abstract:<h2 class="section-title u-h3 u-margin-l-top u-margin-xs-bottom">Graphical </h2><p><span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1001841721000693-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (177KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1001841721000693-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span></p><p>Chemodynamic therapy (CDT) is an emerging tumor treatment approach that exploiting Fenton reaction to convert hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) into toxic hydroxyl radical (<sup>•</sup>OH). As an important substrate of Fenton reaction, H<sub>2</sub>O<sub>2</sub> plays critical role in <sup>•</sup>OH generation. In this review, we summarize recently developed H<sub>2</sub>O<sub>2</sub>-generating nanomedicines that can promote the production of H<sub>2</sub>O<sub>2</sub> in tumor for enhanced CDT.</p><p>Chemodynamic therapy (CDT) is an emerging endogenous stimulation activated tumor treatment approach that exploiting iron-containing nanomedicine as catalyst to convert hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>) into toxic hydroxyl radical (<sup>•</sup>OH) through Fenton reaction. Due to the unique characteristics (weak acidity and the high H<sub>2</sub>O<sub>2</sub> level) of the tumor microenvironment, CDT has advantages of high selectivity and low side effect. However, as an important substrate of Fenton reaction, the endogenous H<sub>2</sub>O<sub>2</sub> in tumor is still insufficient, which may be an important factor limiting the efficacy of CDT. In order to optimize CDT, various H<sub>2</sub>O<sub>2</sub>-generating nanomedicines that can promote the production of H<sub>2</sub>O<sub>2</sub> in tumor have been designed and developed for enhanced CDT. In this review, we summarize recently developed nanomedicines based on catalytic enzymes, nanozymes, drugs, metal peroxides and bacteria. Finally, the challenges and possible development directions for further enhancing CDT are prospected</p>
chemistry, multidisciplinary
What problem does this paper attempt to address?